InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-15 · accession 0001209191-22-054000 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-18 2022-10-17 WGS Ryan Jason Executive COB, Dir S - Sale+OE $0.86 -1,281 15.8K -7% -$1,102
D 2022-10-18 2022-10-15 WGS Ryan Jason Executive COB, Dir M - OptEx — +4,278 17.1K +33% —
D 2022-10-18 2022-10-15 WGS Ryan Jason Executive COB, Dir M - OptEx $0.00 -4,278 8,558 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-10-17 S D 1,281 $0.86 15,833 D — —
2 Common Class A Common Stock 2022-10-15 M A 4,278 — 17,114 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2022-10-15 M D 4,278 $0.00 8,558 D — · — to — 4,278 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.